Abstract
The kinetics of a single oral dose of sodium valproate was studied in six healthy elderly patients (age 68-89 years) and six young control subjects (age 24-26 years). The profiles of total plasma valproic acid (VPA) concentrations were very similar in the elderly and in the young. Half-lives (15.3 +/- 0.7 s.e. mean in the elderly vs 13.0 +/- 1.0 h in the young), volumes of distribution (0.16 +/- 0.01 l/kg in the elderly vs 0.14 +/- 0.01 l/kg in the young) and clearance (7.5 +/- 0.9 ml h-1 kg-1 in the elderly vs 7.7 +/- 0.6 ml h-1 kg-1 in the young) did not differ significantly between the two groups. Free VPA concentrations were significantly increased in the elderly. The clearance of the free drug (intrinsic clearance) was reduced from 127.0 +/- 12 ml h-1 kg-1 (control value in the young) to 77.7 +/- 5.5 ml h-1 kg-1 (P less than 0.02). Free VPA fraction was 9.5 +/- 0.6% in the elderly and 6.6 +/- 0.5% in the young (P less than 0.02). These findings suggest that the pharmacokinetic alterations of VPA in old age are complex and include at least two separate mechanisms: a decrease in plasma protein binding and a reduction of drug metabolizing capacity resulting in decreased clearance of free drug by the liver.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Albani F., Riva R., Procaccianti G., Baruzzi A., Perucca E. Free fraction of valproic acid: in vitro time-dependent increase and correlation with free fatty acid concentration in human plasma and serum. Epilepsia. 1983 Feb;24(1):65–73. doi: 10.1111/j.1528-1157.1983.tb04867.x. [DOI] [PubMed] [Google Scholar]
- Bryson S. M., Verma N., Scott P. J., Rubin P. C. Pharmacokinetics of valproic acid in young and elderly subjects. Br J Clin Pharmacol. 1983 Jul;16(1):104–105. doi: 10.1111/j.1365-2125.1983.tb02151.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Greenblatt D. J., Sellers E. M., Shader R. I. Drug therapy: drug disposition in old age. N Engl J Med. 1982 May 6;306(18):1081–1088. doi: 10.1056/NEJM198205063061804. [DOI] [PubMed] [Google Scholar]
- Gugler R., von Unruh G. E. Clinical pharmacokinetics of valproic acid. Clin Pharmacokinet. 1980 Jan-Feb;5(1):67–83. doi: 10.2165/00003088-198005010-00002. [DOI] [PubMed] [Google Scholar]
- Levy R. H. Monitoring of free valproic acid levels? Ther Drug Monit. 1980;2(2):199–201. doi: 10.1097/00007691-198004000-00015. [DOI] [PubMed] [Google Scholar]
- Perucca E. Free level monitoring of antiepileptic drugs. Clinical usefulness and case studies. Clin Pharmacokinet. 1984 Jan;9 (Suppl 1):71–78. doi: 10.2165/00003088-198400091-00009. [DOI] [PubMed] [Google Scholar]
- Perucca E., Gatti G., Frigo G. M., Crema A., Calzetti S., Visintini D. Disposition of sodium valproate in epileptic patients. Br J Clin Pharmacol. 1978 Jun;5(6):495–499. doi: 10.1111/j.1365-2125.1978.tb01663.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ramsay L. E., Tucker G. T. Clinical pharmacology: drugs and the elderly. Br Med J (Clin Res Ed) 1981 Jan 10;282(6258):125–127. doi: 10.1136/bmj.282.6258.125. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rapeport W. G., Mendelow A. D., French G., MacPherson P., Teasdale E., Agnew E., Thompson G. G., Brodie M. J. Plasma protein-binding and CSF concentrations of valproic acid in man following acute oral dosing. Br J Clin Pharmacol. 1983 Oct;16(4):365–369. doi: 10.1111/j.1365-2125.1983.tb02179.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wilkinson G. R., Shand D. G. Commentary: a physiological approach to hepatic drug clearance. Clin Pharmacol Ther. 1975 Oct;18(4):377–390. doi: 10.1002/cpt1975184377. [DOI] [PubMed] [Google Scholar]